|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.KR |
First Approval Date04 Nov 1996 |
100 Clinical Results associated with Ipsen (Tianjin) Pharmaceutical Trade Co., Ltd.
0 Patents (Medical) associated with Ipsen (Tianjin) Pharmaceutical Trade Co., Ltd.
100 Deals associated with Ipsen (Tianjin) Pharmaceutical Trade Co., Ltd.
100 Translational Medicine associated with Ipsen (Tianjin) Pharmaceutical Trade Co., Ltd.